Page 1 Nyrada Inc. Level 3, 828 Pacific Highway, Gordon NSW 2072 ARBN 625 401 818 5 August 2026 Sydney, Australia Notice of Change of Interests of Substantial Securityholder (“Notice”) Nyrada Inc (ASX: NYR), a clinical-stage biotechnology company focused on ...
Change in substantial holding - M Azzi
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Nyrada
Later from Nyrada
- Appendix 4G and Corporate Governance Statement
- Preliminary Final Report
- Annual Report for year ended 30 June 2026
- Nyrada Full Year Results FY2026
- Xolatryp Demonstrates Cardioprotection in Preclinical Study
Follow Nyrada into a list and get an email when it puts out news.
Follow Nyrada